Health

NEW AMAZFIT BIP 5 GOES BIGGER AND SMARTER WITH AN EXTRA-LARGE SCREEN, 70+ DOWNLOADABLE APPS AND GAMES, AND MORE

MILPITAS, Calif., Aug. 1, 2023 /PRNewswire/ -- Amazfit , a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), a health technology company, has today made the new Amazfit Bip 5 globally available. Encouraging users to "Go Bigger, Go Smarter", the Ama...

2023-08-01 20:00 1590

Peijia Medical Announces First Chinese Patient Implanted with TaurusTrio™ Transcatheter Aortic Valve Replacement System

SUZHOU, China, Aug. 1, 2023 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutic and neurointerventional procedural medical device markets, announced onJuly 31, 2023 that the first Chinese patient of the multi-center ...

2023-08-01 20:00 2292

Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

The Company now has exclusive rights to a US and Chinese patent. SINGAPORE, Aug. 1, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore -based biopharmaceutical company focused on harnessing its proprietary technologies ...

2023-08-01 19:00 1434

Doer Biologics Announces First Subject Dosed in Phase I 12-Week Multiple-Ascending Dose (MAD) Clinical Trial of DR10624 and Received IND Approval From NMPA

HANGZHOU, China, Aug. 1, 2023 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its first-in-class (FIC), tri-specific agonist targeting...

2023-08-01 17:08 1142

Hybribio showcased cutting-edge cervical cancer HPV diagnostic solutions at ADLM 2023

ANAHEIM, Calif., July 31, 2023 /PRNewswire/ -- Hybribio (300639.SZ) exhibited live at the 75th ADLM (former AACC) Annual Scientific Meeting & Clinical Lab Expo,July 25-27, at Anaheim Convention Center, California, USA. This event attracted 958 exhibitors and over 70,000 attendees worldwide from d...

2023-08-01 01:00 1788

Seegene unveils solutions to popularize molecular diagnostics at 2023 AACC

* Introduced syndromic quantitative PCR assays and a fully automated molecular diagnostic testing system, STARlet AIOS™ * Conducted symposium sessions on the usefulness of PCR testing in diagnosing gastrointestinal diseases * Participated in a presentation event for major Korean in-vitro dia...

2023-08-01 00:00 1400

Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together

BOSTON, July 31, 2023 /PRNewswire/ -- On July 25, 2023, Fosun Health Capital established by Fosun Pharma (stock code:600196.SH), reached a strategic partnership with Medicilon (stock code: 688202.SH). Meanwhile StarMab Biology (Suzhou) (jointly invested by the innovation drug research fund of Fo...

2023-07-31 20:30 2193

Skincare Tech Brand AMIRO Receives QTL Certification from SGS to Strengthen R&D Efforts

SHENZHEN, China, July 31, 2023 /PRNewswire/ -- AMIRO ("the Company"), a leading beauty and skincare technology brand, is thrilled to announce that its research facility,AMIRO LAB, has successfully obtained the Qualified Testing Location (QTL) certification after a comprehensive audit conducted by...

2023-07-31 20:15 1577

WuXi AppTec Announced Strong Results of the Second Quarter and First Half of 2023, on Top of an Exceptionally Strong Year in 2022

* Revenue of RMB9,908 Million in the Second Quarter, Up 6.7% Year-over-Year; Excluding COVID-19 Commercial Projects, Up 39.5% * Revenue of RMB18,871 Million in the First Half, Up 6.3% Year-over-Year; Excluding COVID-19 Commercial Projects, Up 27.9% * Net Profit Attributable to Owners of the Co...

2023-07-31 18:02 4079

111 to Announce Second Quarter 2023 Unaudited Financial Results on August 24, 2023 - Conference Call to Follow

SHANGHAI, July 31, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial result...

2023-07-31 17:59 1640

Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI-045B in Atopic Dermatitis (ADAMANT)

NEWARK, N.J. and NANJING, China, July 31, 2023 /PRNewswire/ -- Biosion USA, Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced the phase 2 study initiation for the evaluation of BSI-045B, an anti-TLSP mAb, in the treatment of atopic dermatitis (AD) . "We are pleas...

2023-07-31 17:05 1515

GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME

* YONDELIS® (trabectedin) now PBS listed for Australian patients * Listing described as "wonderful news" for patients living with rare lipo and leiomyo sarcomas * YONDELISÒ (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine1 SINGAPORE, July 31...

2023-07-31 15:00 1666

U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin Intravenous (Human), 10% Liquid)

YONGIN, South Korea, July 31, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a global biopharmaceutical company dedicated to specialty plasma-derived therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company's resubmission of the Biologics License App...

2023-07-31 13:20 1678

J INTS BIO, Novel Oral 4th Generation EGFR TKI 'JIN-A02' - Dosing of First Patient in the Global Multi-center Phase 1/2 Clinical Study began

SEOUL, South Korea, July 31, 2023 /PRNewswire/ -- J INTS BIO announced the successful dosing of the first patient in its global multi-center Phase 1/2 clinical study of 'JIN-A02' on 31st July at Severance Hospital, Seoul, Korea. J INTS...

2023-07-31 13:10 1332

Akeso Inc. Published 2023 Interim Results Positive Profit Alert

HONG KONG, July 31, 2023 /PRNewswire/ -- Akeso Inc. ("Akeso", the "Company"; 9926.HK), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and best-in-class innovative medicines globally, today announced that it is expected that the Company will r...

2023-07-31 12:33 3820

NMPA and FDA Approved the First-in-Human Clinical Trial Applications to Evaluate LBL-034, An Anti-GPRC5D/CD3 Bispecific Antibody Developed by Leads Biolabs, in Relapsed/Refractory Multiple Myeloma

NANJING, China, July 31, 2023 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs" or "Company") announced today that the National Medical Products Administration (NMPA) and the U.S. Food and Drug Administration (FDA) have approved its first-in-human Investi...

2023-07-31 12:09 1248

VARON Reiterates Its Commitment to Brand Value and Its Determination to Reshape the Oxygen Concentrator Industry

SEATTLE, July 28, 2023 /PRNewswire/ -- VARON has built a strong brand reputation by consistently providing practical and preferential oxygen concentrators that improve the lives of individuals with respiratory conditions. By optimizing products and services, VARON continue...

2023-07-28 22:20 2578

Dr. Dapeng Liu: ChatGPT Redefines Medical Device As AI Medical Milestones

SHANGHAI, July 28, 2023 /PRNewswire/ -- In the ever-evolving world of AI, ChatGPT has emerged as a groundbreaking technology, capturing the attention of tech enthusiasts and industry experts alike. Within a short span of time, it has presented new challenges and opportunities for transformative c...

2023-07-28 21:20 2646

Fresh2 Group Ltd. Completes Acquisition of SpeedIn INC, a Delivery Service Provider

NEW YORK, July 28, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: FRES) ("Fresh2," the "Company" or "we"), a company with operations inthe United States and China focused on the business-to-business e-commerce and supply chain sectors for the restaur...

2023-07-28 21:00 8035

Derm Favorite Skincare Brand COSRX's Revenue Rises 138% YoY in the First Half of 2023

LOS ANGELES, July 28, 2023 /PRNewswire/ -- COSRX, a skincare brand favored by dermatologists, has recently revealed an impressive year-on-year growth of 138% in the first half of 2023. This remarkable achievement signifies an anticipated two-fold increase by the end of 2023, further reinforcing i...

2023-07-28 21:00 2941
1 ... 82838485868788 ... 279